On-Q-Ity Raises Additonal $5M in Series A Financing

On-Q-ity, a Waltham, MA-based oncology diagnostics company developing products to improve cancer therapy effectiveness, has closed an additional $5m financing from Atlas Venture, as part of its Series A funding.
This additional investment has brought the company ’s total Series A funding to $26m.
Atlas joins Bessemer Venture Partners, Physic Ventures and Northgate Capital, as an investor in the round led by MDV-Mohr Davidow Ventures.
Bruce Booth, a partner at Atlas Venture, will join the company’s board of directors, which includes Sue Siegel from MDV, Steve Kraus from Bessemer Venture Partners and Dion Madsen from Physic Ventures.

Join the discussion